UR-144
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about UR-144?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
UR-144 (TMCP-018, KM-X1, MN-001, YX-17) is a drug invented by Abbott Laboratories,[2] that acts as a selective full agonist of the peripheral cannabinoid receptor CB2, but with much lower affinity for the psychoactive CB1 receptor.
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | different brandnames, typical example: "TMCP-018", "KM-X1", "UR-144", "MN-001", "YX-17" |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H29NO |
Molar mass | 311.469 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) |
Close